Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Acta Virologica|April 1, 1997
Stable transfection of provirus of human immunodeficiency virus into a murine packaging cell lineC Rozera, S Baccarini, M Gentile, et al.
Journal of Cell Science|May 1, 1990
High-resolution surface views of human lymphocytes during capping of CD4 and HLA antigens as revealed by immunogold fracture-flipA Pavan, P Mancini, G Lucania, et al.
Cellular Immunology|March 1, 1985
Receptors for thymosin alpha 1 on mouse thymocytesC Rinaldi Garaci, M R Torrisi, T Jezzi, et al.
International Journal of Cancer|December 15, 1994
Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) contentS Zanardi, F Pensa, R Torrisi, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 1, 1989
Capping of HLA antigens in human lymphocytes as followed by immunogold label-fractureA Pavan, P Mancini, M Cirone, et al.
Journal of Virology|December 1, 1995
Redistribution of microtubules and Golgi apparatus in herpes simplex virus-infected cells and their role in viral exocytosisE Avitabile, S Di Gaeta, M R Torrisi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1994
Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patientsR Torrisi, S Parodi, V Fontana, et al.
Cancer|October 1, 1989
Postoperative adjuvant external-beam radiotherapy in surgical stage I endometrial carcinomaJ R Torrisi, W A Barnes, G Popescu, et al.
Cancer Detection and Prevention|January 1, 1991
Identification of breast cyst subpopulations: biochemical and morphological featuresS Zanardi, G Valenti, R Torrisi, et al.
Acta Endocrinologica|October 1, 1993
Long-term endocrine effects of administration of either a non-steroidal antiandrogen or a luteinizing hormone-releasing hormone agonist in men with prostate cancerA Decensi, R Torrisi, V Fontana, et al.
Pageof 16